ASX - By Stock
|
NEU |
Re:
Ann: Trofinetide accepted for Priority Review by Health Canada
|
|
goldenchook
|
8 |
3.7K |
40 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
8
|
3.7K
|
40
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
9.9K |
4.4M |
16 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
goldenchook
|
91 |
51K |
65 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
91
|
51K
|
65
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
8.6K |
9 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
40
|
8.6K
|
9
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
8.6K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
40
|
8.6K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
8.6K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
40
|
8.6K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
goldenchook
|
91 |
51K |
15 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
91
|
51K
|
15
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
8.6K |
4 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
40
|
8.6K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
8.6K |
5 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
40
|
8.6K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
8.6K |
6 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
40
|
8.6K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
33 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
421
|
187K
|
33
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
33 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
421
|
187K
|
33
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
9.9K |
4.4M |
30 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
30
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase III Clinical Trial Investor Webinar
|
|
goldenchook
|
92 |
26K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
92
|
26K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
26 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
421
|
187K
|
26
|
|
Charts
|
NEU |
Re:
Positive Reports
|
|
goldenchook
|
41 |
17K |
23 |
04/03/24 |
04/03/24 |
Charts
|
41
|
17K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
goldenchook
|
130 |
61K |
38 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
130
|
61K
|
38
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
goldenchook
|
130 |
61K |
37 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
130
|
61K
|
37
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
goldenchook
|
130 |
61K |
30 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
130
|
61K
|
30
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
35 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
421
|
187K
|
35
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
22 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
421
|
187K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
17 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
421
|
187K
|
17
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase III Clinical Trial Investor Webinar
|
|
goldenchook
|
92 |
26K |
14 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
92
|
26K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
42 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
421
|
187K
|
42
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
goldenchook
|
316 |
159K |
10 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
316
|
159K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
goldenchook
|
316 |
159K |
67 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
316
|
159K
|
67
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
goldenchook
|
316 |
159K |
46 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
316
|
159K
|
46
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
10 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
421
|
187K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
11 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
421
|
187K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
PLEASE DONATE FOR MELLAN ! GoFundMe
|
|
goldenchook
|
91 |
30K |
40 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
91
|
30K
|
40
|
|
ASX - By Stock
|
NEU |
Re:
PLEASE DONATE FOR MELLAN ! GoFundMe
|
|
goldenchook
|
91 |
30K |
15 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
91
|
30K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
PLEASE DONATE FOR MELLAN ! GoFundMe
|
|
goldenchook
|
91 |
30K |
7 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
91
|
30K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2023 quarterly activity report
|
|
goldenchook
|
24 |
10K |
19 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
24
|
10K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Katelin’s Turn is HERE!!!
|
|
goldenchook
|
211 |
108K |
21 |
28/01/24 |
28/01/24 |
ASX - By Stock
|
211
|
108K
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
goldenchook
|
121 |
52K |
3 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
121
|
52K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
goldenchook
|
121 |
52K |
14 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
121
|
52K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
9.9K |
4.4M |
29 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
29
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Feedback
|
|
goldenchook
|
47 |
22K |
98 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
47
|
22K
|
98
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
9.9K |
4.4M |
5 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
9.9K |
4.4M |
17 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
9.9K |
4.4M |
41 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
41
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
goldenchook
|
166 |
75K |
24 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
75K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Rollout
|
|
goldenchook
|
128 |
63K |
95 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
128
|
63K
|
95
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
goldenchook
|
208 |
84K |
39 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
208
|
84K
|
39
|
|
ASX - By Stock
|
NEU |
Re:
Take Over Opportunity
|
|
goldenchook
|
42 |
20K |
35 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
42
|
20K
|
35
|
|
ASX - By Stock
|
NEU |
Re:
Psychiatric Indications
|
|
goldenchook
|
16 |
7.3K |
4 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
16
|
7.3K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
goldenchook
|
249 |
107K |
8 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
249
|
107K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
14 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
421
|
187K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
goldenchook
|
208 |
84K |
30 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
208
|
84K
|
30
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
421 |
187K |
15 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
421
|
187K
|
15
|
|